Real‐world treatment outcomes of neovascular Age‐related Macular Degeneration in the Netherlands

PURPOSE: To compare treatment outcomes of treatment‐naïve eyes with neovascular age‐related macular degeneration (nAMD) with bevacizumab as the first‐line treatment, according to the guidelines of the Dutch Ophthalmological Society, with those treated first with either ranibizumab or aflibercept, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Verbraak, Frank D., Ponsioen, Dirk L., Tigchelaar‐Besling, Odette A.M., Nguyen, Vuong, Gillies, Mark C., Barthelmes, Daniel, Klaver, Caroline C.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519105/
https://www.ncbi.nlm.nih.gov/pubmed/33354933
http://dx.doi.org/10.1111/aos.14712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519105/
https://www.ncbi.nlm.nih.gov/pubmed/33354933
http://dx.doi.org/10.1111/aos.14712

Ejemplares similares